Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS5405

Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells

Analysis of patient PTCL/NOS cells treated with imatinib mesylate (1uM, 6h). PTCL/NOS tumors are characterized by aberrant expression of platelet-derived growth factor receptor α (PDGFRA). Results provide insight into the molecular effects of inhibiting PDGFRA signaling by imatinib.

Organism:: Homo sapiens

Type:: Expression profiling by array, transformed count, 2 agent sets

Platform:: GPL570
Series:: GSE53633
4 Samples

Download data: CEL

DataSet

Accession:: GDS5405

ID:: 5405

PubMed Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise s...
Imatinib mesylate effect on patient peripheral T-cell lymphomas, not otherwise specified (PTCL/NOS) cells
Accession: GDS5405

GEO DataSets
Related DataSets for GEO Profiles (Select 124984182) (1)
GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets